ES2078462T3 - Esteres de castanoespermina anti-herpes. - Google Patents

Esteres de castanoespermina anti-herpes.

Info

Publication number
ES2078462T3
ES2078462T3 ES91311275T ES91311275T ES2078462T3 ES 2078462 T3 ES2078462 T3 ES 2078462T3 ES 91311275 T ES91311275 T ES 91311275T ES 91311275 T ES91311275 T ES 91311275T ES 2078462 T3 ES2078462 T3 ES 2078462T3
Authority
ES
Spain
Prior art keywords
esters
herpes
castanoespermina
active
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91311275T
Other languages
English (en)
Inventor
A Stanley Tyms
Paul Saiho Liu
Debra L Taylor
Prasad S Sunkara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2078462T3 publication Critical patent/ES2078462T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)

Abstract

ESTERES CASTANOSPERMINAS ACTIVOS EN EL TRATAMIENTO DE LAS INFECCIONES VIRALES HERPES.
ES91311275T 1990-12-18 1991-12-04 Esteres de castanoespermina anti-herpes. Expired - Lifetime ES2078462T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027433A GB9027433D0 (en) 1990-12-18 1990-12-18 Anti-herpes castanospermine esters

Publications (1)

Publication Number Publication Date
ES2078462T3 true ES2078462T3 (es) 1995-12-16

Family

ID=10687190

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91311275T Expired - Lifetime ES2078462T3 (es) 1990-12-18 1991-12-04 Esteres de castanoespermina anti-herpes.

Country Status (20)

Country Link
US (1) US5385911A (es)
EP (1) EP0492841B1 (es)
JP (1) JPH04342587A (es)
KR (1) KR100192642B1 (es)
AT (1) ATE126435T1 (es)
AU (1) AU643098B2 (es)
CA (1) CA2057821A1 (es)
DE (1) DE69112192T2 (es)
DK (1) DK0492841T3 (es)
ES (1) ES2078462T3 (es)
FI (1) FI915929A (es)
GB (1) GB9027433D0 (es)
GR (1) GR3017152T3 (es)
HU (1) HU210257B (es)
IE (1) IE914400A1 (es)
IL (1) IL100233A (es)
NO (1) NO914986D0 (es)
NZ (1) NZ240976A (es)
PT (1) PT99835B (es)
ZA (1) ZA919808B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466714A (en) * 1987-12-31 1995-11-14 Research Foundation For Mental Health Hygiene, Inc. Spermicidal and cytocidal fatty acid compositions
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
WO2001054692A1 (en) * 2000-01-28 2001-08-02 Synergy Pharmaceuticals, Inc. Use of castanospermine and substituted-castanospermine compounds for treating hepatitis virus infections
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
GB0116643D0 (en) * 2001-07-09 2001-08-29 Virogen Ltd Antiviral compounds
US7930711B2 (en) * 2003-03-06 2011-04-19 Wegener Communications, Inc. Apparatus and method for addressing control in a network for distributed data
MX2007003853A (es) * 2004-10-06 2007-11-21 Migenix Inc Composiciones antivirales en combinacion que comprenden castanospermina y metodos de uso.
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
WO2008088581A2 (en) * 2006-08-02 2008-07-24 United Therapeutics Corporation Liposome treatment of viral infections
EP2282723A2 (en) * 2008-03-26 2011-02-16 University of Oxford Endoplasmic reticulum targeting liposomes
EP2410989A2 (en) * 2009-03-27 2012-02-01 The Chancellor, Masters and Scholars of the University of Oxford Cholesterol level lowering liposomes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760079A (en) * 1983-01-10 1988-07-26 Baltech, Inc. Treatment of diseases caused by herpes viruses
US4628063A (en) * 1984-03-08 1986-12-09 Dana P. Brigham Antiviral pharmaceutical preparations and methods for their use
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
JPS61227566A (ja) * 1985-04-01 1986-10-09 Fujisawa Pharmaceut Co Ltd スワインソニンおよび関連化合物の合成法
US4751236A (en) * 1987-05-20 1988-06-14 Avihou Mishniot Method for treating genital herpes
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
US5017563A (en) * 1988-06-23 1991-05-21 Merrell Dow Pharmaceuticals Inc. Castanospermine esters and glycosides

Also Published As

Publication number Publication date
AU643098B2 (en) 1993-11-04
IE914400A1 (en) 1992-07-01
NZ240976A (en) 1997-03-24
DK0492841T3 (da) 1995-09-18
DE69112192D1 (de) 1995-09-21
FI915929A0 (fi) 1991-12-17
JPH04342587A (ja) 1992-11-30
PT99835A (pt) 1992-12-31
EP0492841A1 (en) 1992-07-01
HUT59924A (en) 1992-07-28
HU210257B (en) 1995-03-28
PT99835B (pt) 1999-06-30
ZA919808B (en) 1992-09-30
DE69112192T2 (de) 1996-04-04
KR920011488A (ko) 1992-07-24
IL100233A (en) 1996-03-31
NO914986D0 (no) 1991-12-17
KR100192642B1 (ko) 1999-06-15
GR3017152T3 (en) 1995-11-30
IL100233A0 (en) 1992-09-06
CA2057821A1 (en) 1992-06-19
GB9027433D0 (en) 1991-02-06
US5385911A (en) 1995-01-31
EP0492841B1 (en) 1995-08-16
HU913989D0 (en) 1992-03-30
AU8964191A (en) 1992-06-25
FI915929A (fi) 1992-06-19
ATE126435T1 (de) 1995-09-15

Similar Documents

Publication Publication Date Title
DE69310830D1 (de) CMOS-Differenzverstärker mit Gleichtaktgegenkopplung
DK0464558T3 (da) Antimigræne-alkoxypyrimidinderivater
ES2078462T3 (es) Esteres de castanoespermina anti-herpes.
DE69118501T2 (de) Wechselrichteranordnung
FI910254A (fi) Oralt aktiva renininhibitorer.
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
ES2055030T3 (es) Antibioticos de 1-carbacefalosporina.
DE69216122D1 (de) Optisch aktive 1,3-Dioxin-4-one
FI945035A (fi) Pintasterilisointi laserkäsittelyn avulla
DE69130099D1 (de) Antineoplastischer wirkstoff
DE3579140D1 (de) Arzneimittel mit einem 6-substituierten adenosin als aktives bestandteil.
ITRM920063V0 (it) Il gioco del pentathlon militare
SE8604669D0 (sv) Medel for behandling av svampinfektioner i naglar
KR910016253U (ko) 코너용 캐스터를 부설한 소프트트렁크(soft trunk)
DK97192D0 (da) Lysindfald i gavl paa ovenlys
NO903568D0 (no) Utnyttbare energikilder paa kjoeretoeyer.
BR9004135A (pt) Jogo de mesa
ITLI920008U1 (it) Gioco del totovolley
KR920011809U (ko) 사이드 밀러
UY2864U (es) Cono descartable
NO903796D0 (no) Fremgangsmaate for fremstilling av optisk aktive epoksyder.
IT9019775A1 (it) Dispositivo di sollevamento in presenza di ruote
BR8706179A (pt) Espelho com desembacador

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 492841

Country of ref document: ES